SFI
IDYA icon

Susquehanna Fundamental Investments’s IDEAYA Biosciences IDYA Stock Holding History

Susquehanna Fundamental Investments’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,016
Closed -$357K – 1593
2021
Q3 		$357K Buy
+14,016
New +$327K 0.01% 1339

Other funds holding IDYA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Susquehanna Fundamental Investments's IDYA Position: Q4 2021 in Review

Susquehanna Fundamental Investments sold out of IDEAYA Biosciences (IDYA) in Q4 2021, closing a stake of 14,016 shares — an estimated $357K sold.

Susquehanna Fundamental Investments first reported a position in IDYA in Q3 2021 and held it in 1 quarter. The position peaked at $357K in Q3 2021. 110 funds tracked by Wall St. Rank hold IDYA as of Q4 2021.

  • Susquehanna Fundamental Investments reported no remaining IDEAYA Biosciences position as of Q4 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 14,016 IDEAYA Biosciences shares in Q4 2021, an estimated $357K.
  • Susquehanna Fundamental Investments first reported a position in IDEAYA Biosciences in Q3 2021 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's IDEAYA Biosciences position peaked at $357K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2021, filed 14 Feb 2022.